The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A definitive model for predicting absolute risk of coronary heart disease (CHD) in male and female people with Type II diabetes is not yet available. This paper provides an equation for estimating the risk of new CHD events in people with Type II diabetes, based on data from 4540 U.K. Prospective Diabetes Study male and female patients. Unlike previously published risk equations, the model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes. All variables included in the final model were statistically significant (P<0.001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lower the CAD risk, the higher the chance of a false positive”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [248]
In the citing paper
“During the entire follow-up period, the rate of death among patients in the conventionaltherapy group was 50%, a finding that underscores the poor prognosis for such patients in the absence of intensive treatment.20”
From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [20]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Self-citationStratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Self-citationPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Cited by
Items 901–1,000 of 1,000
Prediction of Coronary Heart Disease Risk in Korean Patients with Diabetes Mellitus
Koo, B. K., Oh, S., Kim, Y. J., & Moon, M. K. (2018) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2018.7.2.110 · Cited by 6
Lithovius, R., Antikainen, A. A., Mutter, S., Valo, E., Forsblom, C. M., Harjutsalo, V., Sandholm, N., & Groop, P. (2022) · Diabetes Care · doi:10.2337/dc21-0974 · Cited by 6
Xu, Z., Arnold, M., Sun, L., Stevens, D., Chung, R., Ip, S., Barrett, J., Kaptoge, S. K., Pennells, L. A. M., Angelantonio, E. D., et al. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac140 · Cited by 5
Siebenhofer, A., Jeitler, K., Rakovac, I., & Horvath, K. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02821.x · Cited by 5
A simple linear model for the effect of changes in metabolic risk factors on coronary heart disease
Møgelvang, R., Scharling, H., & Jensen, J. S. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01634.x · Cited by 5
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2006) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2006-12-2-99-116 · Cited by 7
Masson, W. M., Francesca, S. D., Molinero, M., Siniawski, D. A., Mulassi, A., Espinoza‐Morales, F., Huerin, M. S., Lobo, M., & Molinero, G. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000234 · Cited by 6
“One of the few risk scores specifically developed in a population with diabetes came from the United Kingdom Prospective Diabetes Study (UKPDS risk engine) (12).”
Backgroundde Jong, A. J., Zuidgeest, M. G. P., Santa‐Ana‐Téllez, Y., Hallgreen, C. E., van Sloten, T. T., de Boer, A., & Gardarsdóttir, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104304 · Cited by 6
Mita, T., Osonoi, Y., Someya, Y., Osonoi, T., Saito, M., Nakayama, S., Ishida, H., Ishii, R., Gosho, M., & Watada, H. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf179 · Cited by 4
Yoshida, Y., Li, D., Li, X., Rohatgi, A. K., Bazzano, L., Fonseca, V. A., Qi, L., & Mauvais‐Jarvis, F. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.08.010 · Cited by 4
“17 We found that LDL, VLDL, and lipid concentrations (eg, TG) in these lipoprotein particles were significantly higher in women than men in the new T2D group.”
Dynamic decision models for managing the major complications of diabetes
Kurt, M. (2012) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 4
Gala, S., & Wu, W. K. (2014) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12066 · Cited by 4
“Clinical trials like the United Kingdom Prospective Diabetes Study and the Diabetes Control and Complication Trials have demonstrated the importance of intensive glucose control and HbA1c monitoring to reduce complications and death from CVD.[3,38,39] Thus, in adults with prior CVD, adherence to diabetes care may be n…”
BackgroundInfluentialPrescott, A., Bailey, J., Kelly, K., Munyombwe, T., Gray, A. M., & Summers, L. K. M. (2012) · Primary care diabetes · doi:10.1016/j.pcd.2011.12.001 · Cited by 5
Ştefan, R., Niţă, C., Craciun, A. E., Rusu, A., & Hâncu, N. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-406 · Cited by 5
Glycemic Variability and Type 2 Diabetes Mellitus
Gribovschi, M., ŢIGAN, Ş. “. H. U. O. M. A. P., & HÂNCU, N. “. M. C. (2013) · Applied Medical Informatics (University of Medicine and Pharmacy Cluj-Napoca) · Cited by 7
Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus
Ward, A., O’Brien, J. A., & Salas, M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.4.601 · Cited by 4
“Recently, risk equations for heart disease and fatality from myocardial infarction and stroke have been made available by UKPDS and will probably, and should, be incorporated into future models [39,40].”
BackgroundTerrés-Speziale, A. M. (2006) · Revista Latinoamericana de Patología Clínica y Medicina de Laboratorio · Cited by 8
Diabetic Dyslipidemia and Risk of Cardiovascular Disease
Viljoen, A., Joshi, S., & Wierzbicki, A. S. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch43 · Cited by 6
Tan, S. Y., Cronin, H., Byrne, S., O’Donovan, A., & Tuthill, A. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02649-5 · Cited by 4
“The 10-year cardiovascular risk for persons with type 2 diabetes without CVD was estimated using the UK Prospective Diabetes Study (UKPDS) risk stratification tool [15].”
MethodBerg, D. D., Kolkailah, A. A., Sarraju, A., Kerchberger, A. M., Eljalby, M., & McGuire, D. K. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01417-0 · Cited by 4
2021. évi ESC-irányelvek a szív- és érrendszeri betegségek megelőzéséről a klinikai gyakorlatban
Szabados, E., Sándor, B., & Pálfi, A. (2022) · Cardiologia Hungarica · doi:10.26430/chungarica.2022.52.5.60 · Cited by 5
Lei, M., Hsu, Y.-C., Chung, S., Chen, C.-C., Chen, W.-C., Chen, W., Jao, A.-T., Hsiao, J., Hsu, J., & Wu, S. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01341-9 · Cited by 4
New worldwide lipid guidelines
Saraf, S., & Ray, K. K. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000184 · Cited by 4
Cardiac risk is not associated with hypertension treatment intensification.
Sussman, J. B., Zulman, D. M., Hayward, R. A., Hofer, T. P., & Kerr, E. A. (2012) · PubMed · Cited by 4
Gang, L., Lü, W., Ai, R., Yang, J., Zi-Hua, Z., & Tang, Z. (2014) · Angiology · doi:10.1177/0003319714548566 · Cited by 4
Physical health in schizophrenia and related disorders
Ismail, K. (2008) · Psychiatry · doi:10.1016/j.mppsy.2008.08.001 · Cited by 4
Roach, P. J., Klindukhova, O., Saha, C., Hudson, B. L., Cantrell, M., & Marrero, D. G. (2010) · Diabetes Spectrum · doi:10.2337/diaspect.23.3.155 · Cited by 5
Buonaiuto, G., Mori, V. D., Braus, A., Balini, A., Berzi, D., Carpinteri, R., Forloni, F., Meregalli, G., Ronco, G. L., & Bossi, A. C. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000216 · Cited by 4
“Sitagliptin obtained significant results after 12 months, and at the end of the observation (48 months), on metabolic control (expressed by HbA1c) and on UKPDS RE.”
BackgroundInfluentialBossi, A. C., Mori, V. D., Galeone, C., Bertola, D. P., Gaiti, M., Balini, A., Berzi, D., Forloni, F., Meregalli, G., & Turati, F. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001507 · Cited by 4
Separation of Lipoxygenase and Estimation of its Level in Blood of Males with Cardiovascular Disease
Mahmood, A. A., & Rashed, R. N. (2013) · Mağallaẗ ʻulūm al-rāfidayn · doi:10.33899/rjs.2013.71260 · Cited by 4
“…was stated that the ratio of TC/HDL-C (but not their absolute value) reflects the real risk factor related to patients with cardiovascular disease; the higher the level of TC/HDL-C, the higher the susceptibility of cardiovascular events (Kumar et al., 2009; Wang et al., 2009; Stevens et al., 2001).”
BackgroundRisk Models and Scores of Cardiovascular Disease in Patients with Diabetes Mellitus
Kostopoulos, G., Antza, C., Doundoulakis, I., & Toulis, K. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201210112743 · Cited by 5
Bruninx, A., Scheenstra, B., Dekker, A. L. A. J., Maessen, J. G., Hof, A. W. J. V. ’., Kietselaer, B., & Bermejo, I. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101672 · Cited by 4
Schwander, B., Kaier, K., Hiligsmann, M., Evers, S., & Nuijten, M. J. C. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01162-6 · Cited by 5
Sperl‐Hillen, J. M., ANDERSON, J. P., Margolis, K. L., Rossom, R. C., Kopski, K. M., Averbeck, B. M., Rosner, J. A., Ekstrom, H. L., Dehmer, S. P., & O’Connor, P. J. (2022) · JMIR Formative Research · doi:10.2196/32666 · Cited by 4
“The algorithms use published risk-prediction equations [23-25] to calculate an individual’s reversible CV risk potential and then prioritize out-of-control CV risk factors in a list form from the most to the least likely to lower CV risk if successfully addressed.”
MethodAmpuero, D. V., Lorca, M. E. C., Cantillana, C. C., Pérez, D. I. V., Queiroz, A. C. C., dos Santos, D. A., Miarka, B., Nóbrega, O. D. T., & Brito, C. J. (2023) · Journal of Physical Education and Sport · doi:10.7752/jpes.2023.03078 · Cited by 5
Vascular disease in paediatric type 2 diabetes: the state of the art
Vaughan, T. B., Ovalle, F., & Moreland, E. C. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.056 · Cited by 4
“org/diabetesPHD), which is powered by the Archimedes mathematical model and has been extensively validated against clinical trials.(57,58) However, in general, the performance of these equations is quite similar to that of the Framingham-based equations.”
ResultPirraglia, P. A., Taveira, T. H., Cohen, L. B., & Wu, W.-C. (2008) · Preventing Chronic Disease · Cited by 4
Coppell, K. J., Williams, S., Anderson, K., Lamb, C., & Mann, J. I. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.038 · Cited by 4
“The UKPDS Risk Engine [30] was derived from a diabetic study population and includes diabetes specific factors, but study exclusions potentially limit the generalisability of the equa-”
MethodDash, A., Maiti, R., Bandakkanavar, T. K. A., Bhaskar, A., Prakash, J., & Pandey, B. L. (2013) · PubMed Central · Cited by 4
Hoogenveen, R. T., Feenstra, T., van Baal, P. H. M., & Baan, C. A. (2005) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · Cited by 13
Cerghizan, A., Bala, C. G., Niţă, C., & Hâncu, N. (2007) · PubMed · Cited by 4
PROGNOSIS OF UNCONTROLLED DIABETES AND HYPERTENSION LEADS TO SECONDARY COMPLICATIONS: A CASE REPORT
Naeem, H., Ahmad, A., Khan, C. B., & Nawaz, R. K. (2011) · Journal of Applied Pharmacy · doi:10.21065/19204159.3.20 · Cited by 4
Khan, A. A., Chung, M. J., Novak, E. L., & Brown, D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005946 · Cited by 4
Stevens, R., & Holman, R. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1843 · Cited by 4
Self-citationTsuyuki, R. T., Jones, C., & Hemmelgarn, B. R. (2016) · Cited by 3
Principles of Diabetes Care and Lifestyle Modification
Moon, M. K. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_8 · Cited by 3
Ren, W., Fan, K., Liu, Z., Wu, Y., An, H., & Liu, H. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70049 · Cited by 4
Using Electronic Health Records to Monitor and Improve Adherence to Medication
Mason, J. E., Denton, B. T., Wilson, J. R., & Fitts, E. P. (2013) · Cited by 7
Winckler, K., Thorsteinsson, B., Wiinberg, N., Jensen, A. K., Lundby‐Christensen, L., Heitmann, B. L., Lund, S. S., Krarup, T., Jensen, T. J., Vestergaard, H., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107681 · Cited by 5
Koshizaka, M., Ishibashi, R., Maeda, Y., Ishikawa, T., Maezawa, Y., Takemoto, M., & Yokote, K. (2022) · Diabetology International · doi:10.1007/s13340-022-00587-w · Cited by 3
Liu, Q., Qiu, J., Sun, S., Wang, X., Sun, Z., & Zhao, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.974294 · Cited by 3
Hyun, J., Lee, P. H., Lee, J., Yang, Y., Kim, J. H., Kim, T. O., Kang, S.-J., Kim, J. K., Lee, J. S., & Lee, S. (2023) · Revista Española de Cardiología · doi:10.1016/j.recesp.2023.01.001 · Cited by 3
Diabetes mellitus and macrovascular disease: epidemiology and cardiovascular risk assessment
Fan, W., & Wong, N. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99991-5.00011-5 · Cited by 4
Arabidze, G. G., Мамедов, М. Н., & Akhundova, H. R. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3966 · Cited by 3
AI-Driven Precision Medicine and Personalized Healthcare for Immunological Disorders
Poovathanathil, S. A., Barage, S. H., & Singh, R. (2025) · Advances in computational intelligence and robotics book series · doi:10.4018/979-8-3693-9725-1.ch007 · Cited by 4
Piarulli, F., Ragazzi, E., Celsan, C. C., Lapolla, A., & Sartore, G. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01910-6 · Cited by 4
Page, M. M., Sanfilippo, F. M., Geelhoed, E. A., Briffa, T. G., & HOBBS, M. S. T. (2012) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2012.00887.x · Cited by 3
“7 years.(14) CHD events were defined as myocardial infarction (MI) or sudden death.”
BackgroundInfluentialBonora, E., Bryzinski, B. S., Hirshberg, B., & Cook, W. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.11.004 · Cited by 4
Zreik, R., Salti, H. I., Salti, I. S., Boukhalil, R., Haddad, T., & Nasrallah, M. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.64032 · Cited by 3
The Evolving Cardiovascular Disease Risk Scores for Persons with Diabetes Mellitus
Zhao, Y., & Wong, N. D. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1069-5 · Cited by 4
Nouveaux outils d’évaluation du risque cardiovasculaire
Bauduceau, B., & Bordier, L. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30020-3 · Cited by 4
Bovi, T. G., Zantut‐Wittmann, D. E., & Parisi, M. C. R. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.024 · Cited by 3
Fritzen, K., Basinska, K., Stautner, C., Braun, K. F., Rubio-Almanza, M., Nicolucci, A., Kennon, B., Vergès, B. L., Hosny, Y., & Schnell, O. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819864665 · Cited by 3
“Ten-Year Risk Assessment for Nonfatal and Fatal Myocardial Infarctions as Well as Nonfatal and Fatal Strokes for Participants of the ACCENTS Study(11) by the UK Prospective Diabetes Study Risk Engine.(44)”
MethodCaplan, E. O., Hayden, J., Pimple, P. M., Luthra, R., PREWITT, T. G., Chiguluri, V., Kattan, M. W., Goss, A., & Harvey, R. A. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.11.1579 · Cited by 3
Nghiên cứu nồng độ homocystein máu ở bệnh nhân đái tháo đường týp 2 có tổn thương động mạch vành
Chi, N. T. B., & Bình, H. A. (2021) · Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế · doi:10.38103/jcmhch.2021.67.6 · Cited by 3
Balducci, S., Haxhi, J., Vitale, M., Mattia, L., Bollanti, L., Conti, F., Cardelli, P., Sacchetti, M., Orlando, G., Zanuso, S., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110140 · Cited by 5
Bahrami, H., Jørgensen, P. G., Hove, J., Dixen, U., Biering-Sørensen, T., Rossing, P., & Jensen, M. (2023) · European Heart Journal-Cardiovascular Imaging · doi:10.1093/ehjci/jead178 · Cited by 3
de Araujo, F. M., Comim, F. V., Lamounier, R. N., Pena, N. F., Fajardo, V. C., de Faria, R. B. G., Silva, Y. M., & Lauria, M. W. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01224-5 · Cited by 3
“Similarly, the employment of UKPDS calculator, based on the results of The United Kingdom Prospective Diabetes Study which included these factors miscalculated the cardiovascular risk for T1DM subjects [10, 11].”
MethodHe, Z., Cheng, H., Jia, Z., Niu, Z., Li, Y., Huang, W., Guo, V. Y., Su, Z., Xie, Y. J., Shen, J., et al. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14414 · Cited by 3
“Previous studies suggested that the UKPDS risk engine might be more sensitive in estimating coronary heart disease risk in Chinese diabetic population 36,37 .”
Liu, S., Tsuyuki, R. T., Graham, M. M., Nelson, D., Semeniuk, G., & Hamarneh, Y. N. A. (2025) · CJC Open · doi:10.1016/j.cjco.2025.03.011 · Cited by 4
“…their own CV risk online (which uses the same validated CV risk equations d Framingham, 37 the United Kingdom Prospective Diabetes Study (UKPDS), 38 and the Second Manifestations of Arterial Disease (SMART 39 ) equations, on either the patient-friendly version of the trial ’ s webpage) 40 or…”
Priya, A. M., Kanna, P. R., Vanithamani, S., & Kumar, G. S. (2025) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2025.108161 · Cited by 3
Nilsson, P. M., Viljoen, A., & Wierzbicki, A. S. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch40 · Cited by 4
Clinical features and treatment of coronary heart disease in diabetes
Standl, E., Erbach, M., Hanefeld, M., Schnell, O., Stratmann, B., & Tschoepe, D. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch73 · Cited by 3
García‐Ortiz, L., Gómez-Marcos, M. Á., González-Elena, L. J., Maderuelo-Fernández, J. Á., Ramos-Delgado, E., & Torrecilla-Garcia, M. (2007) · Revista Española de Salud Pública · doi:10.1590/s1135-57272007000400004 · Cited by 3
Long term cardiovascular risk models’ combination - a new approach
Paredes, S., Rocha, T., Carvalho, P., Henriques, J. M. O., Harris, M., & Morais, J. (2009) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2009.5334198 · Cited by 6
ScHARR Public Health Collaborating Centre
Walker, V. (2009) · Cited by 3
Ezeiruaku, F. C. (2019) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2019.94015 · Cited by 3
“The increased superoxide production causes the activation of 5 major pathways involved in the pathogenesis of complications [4] [5] [6].”
BackgroundNHG-Standaard Cardiovasculair risicomanagement
Boukes, F., Geijer, R. M. M., Opstelten, W., Wiersma, T., & Goudswaard, A. N. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_20 · Cited by 3
Personal Health Systems for Diabetes Management, Early Diagnosis and Prevention
Zarkogianni, K., & Nikita, K. S. (2018) · IGI Global eBooks · doi:10.4018/978-1-5225-6198-9.ch012 · Cited by 10
Seino, H., Onishi, Y., Eguchi, K., Nishijima, K., Sato, T., & Shirabe, S. (2023) · Diabetology International · doi:10.1007/s13340-022-00612-y · Cited by 3
“No such imputations were necessary to produce the 10-year risk data from the UKPDS risk engine, as it was a pre-specified analysis [21].”
BackgroundMethodInfluentialMatheny, M. E., Ohno-Machado, L., Davis, S. E., & Nemati, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91200-6.00031-0 · Cited by 3
Statin policy and target populations: evidence-based or evidence-biased?
Durrington, P. N. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137223.61901.a9 · Cited by 3
Management of type 2 diabetes mellitus and prediction of cardiovascular complications
van Dieren, S., Health, C., Health, J. O. C., Economics, E. &. H., van der Schouw, Y. T., Beulens, J. W. J., & Peelen, L. M. (2013) · Utrecht University Repository (Utrecht University) · Cited by 5
Exercise therapy in Type 2 Diabetes
Praet, S. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20071214sp · Cited by 4
Khoury, H., Wagner, M., Merikle, E. P., Johnson, S. J., & Roberts, C. S. (2009) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(09)34006-x · Cited by 3
The Synergy of Gamification and Mathematical Modelling in eHealthcare
Kachurina, P., Kolomiytsev, S., Беспалов, А. В., Барчук, А. А., & Pantyukhov, P. (2015) · International Conference on Electronic Governance and Open Society: Challenges in Eurasia (EGOSE) · doi:10.1145/2846012.2846046 · Cited by 2
“Diabetes models are divided into several groups: models, which pay more attention to processes in internals [14; 20], models, which deal with risk factors impact [51] and population factors [10].”
BackgroundWan, K. S., Hairi, N. N., Mustapha, F. I., Yusoff, M. F. M., Ismail, M., Moy, F. M., & Ahmad, N. A. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07204-4 · Cited by 2
“Prospective Diabetes Study (UKPDS), the duration of diabetes and microalbuminuria have been included in the risk engine and estimator [17, 18].”
Barbosa, C., Hoerger, T. J., Mack, N. A., Bobashev, G., Neuwahl, S. J., Hilscher, R., Orchard, T. J., Costacou, T., Miller, R. G., D’Agostino, R., et al. (2025) · Diabetes Care · doi:10.2337/figshare.29315495.v1 · Cited by 2
Current evidence on lipid ratios for cardiovascular risk assessment in diabetes: A review
Carretero-Anibarro, E., & Orozco‐Beltrán, D. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.02.008 · Cited by 2
Siachos, I., Αθανασίου, Μ., Zarkogianni, K., Thanopoulou, A. C., & Nikita, K. S. (2026) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2026.105015 · Cited by 2
Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction
Serés-Noriega, T., Aguiló-Lafarga, I., Perea, V., Viñals, C., & Amor, A. J. (2026) · Annals medicus · doi:10.1080/07853890.2026.2642404 · Cited by 2
“Several tools have been developed for individuals with T2D, such as the one proposed by the United Kingdom Prospective Diabetes Study (UKPDS) [33] and the British QRISK2 model [34].”
Multi-level preventive care for Type 2 diabetes
Aral, K. D., Chick, S. E., & Grabosch, A. (2015) · IIE Transactions on Healthcare Systems Engineering · doi:10.1080/19488300.2015.1060552 · Cited by 2
“…classification (coronary heart disease, stroke, nephropathy, retinopathy, neuropathy), and models intervention effects on several risk factors (HbA1c, lipids and blood pressure) for comorbidities using risk estimates from the UKPDS Risk Engine (Stratton et al., 2000; Stevens et al., 2001).”
MethodShetaban, S., Esfahani, M. M. S., Saghaei, A., & Ahmadi, A. (2020) · Computational Intelligence · doi:10.1111/coin.12418 · Cited by 2
The effect of adherence on antihypertensive therapy plans in patients with diabetes
Mirghorbani, S., Melouk, S. H., & Mittenthal, J. (2021) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2021.1879321 · Cited by 2
“(2017) provide a risk probability model for Myocardial Infarction (MI) that is a serious result of CHDs, and since these two terms have been used interchangeably in the literature (Kurt et al., 2011; Stevens et al., 2001), we use this risk model to estimate CHD risks.”
BackgroundMethodCardiovascular profile of patients with type 2 Diabetes
Ekoundzola, J. R., Chtioui, S., Rafi, S., Mghari, G. E., & Ansari, N. E. (2023) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2023.18.1.0702 · Cited by 2
Pervyshin, N. A., Bulgakova, S. V., Chertischeva, A. A., Galkin, R. A., & Lebedeva, E. A. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-228-8-273-280 · Cited by 2
Ong, R., Ng, C. J., Gunasekaran, K., Liu, H., Hsu, W., Lee, M. L., & Tan, N. C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319992 · Cited by 2
“Validated risk score calculators should still be used for such predictions, such as the UK Prospective Diabetes Study (UKPDS) [41] in the UK and Framingham Adult Treatment Panel (ATP) III [42] in Singapore for cardiovascular disease risk calculation.”
Chang, Y., Lin, K., Shin, S., & Lee, Y. J. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.04.010 · Cited by 2
Goldberg, R. B. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.006 · Cited by 2
Barnard, K. D., & Holt, R. I. G. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch23 · Cited by 2
Metadata
- Authors
- STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M.
- Affiliations
- University of Oxford (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2001-12-01
- Volume
- 101
- Issue
- 6
- Pages
- 671
- ISSN
- 0143-5221 (ISSN-L)
- OpenAlex
- W2117191092
- Cited by
- 1,084
- References
- 51
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 33 · 2022: 44 · 2021: 60 · 2020: 46 · 2019: 42 · 2018: 47 · 2017: 42 · 2016: 39 · 2015: 60 · 2014: 66 · 2013: 68 · 2012: 59
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- coronary artery disease, type 2 diabetes, cardiovascular risk prediction, risk prediction model, glycemia, systolic blood pressure, serum lipids, primary prevention, smoking, sex differences
- MeSH terms
- Adult, Blood Pressure, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Lipids, Male, Middle Aged, Risk Factors, Smoking, Models, Statistical, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.